Similar Articles
121 Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
122 Hepatocellular carcinoma national burden across different geographical regions in the United States between 2001 and 2020
123 Imaging-based prediction of hepatocellular carcinoma recurrence after microwave ablation as bridge therapy: A glimpse into the future
124 Gene targets with therapeutic potential in hepatocellular carcinoma
125 Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy
126 Risk factors for hepatocellular carcinoma in cirrhosis: A comprehensive analysis from a decade-long study
127 Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment
128 Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
129 Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy
130 Current efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA